Prostate Cell News Volume 13.06 | Feb 18 2022

    0
    23







    2022-02-18 | PCN 13.06


    Prostate Cell News by STEMCELL Technologies
    Vol. 13.06 – 18 February, 2022
    TOP STORY

    Melatonin Suppresses the Metastatic Potential of Osteoblastic Prostate Cancers by Inhibiting Integrin α2β1 Expression

    The authors revealed that melatonin concentration-dependently decreased the migratory and invasive abilities of two osteoblastic prostate cancer cell lines by inhibiting FAK, c-Src and NF-κB transcriptional activity via the melatonin MT1 receptor, which effectively inhibited integrin α2β1 expression.
    [Journal of Pineal Research]

    Abstract

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    PUBLICATIONSRanked by the impact factor of the journal

    TRPC3 Shapes the ER-Mitochondria Ca2+ Transfer Characterizing Tumor-Promoting Senescence

    Researchers reported the mechanism altering mitochondrial function and oxidative phosphorylation in stress-induced senescent fibroblasts.
    [Nature Communications]

    Full Article

    RelB Upregulates PD-L1 and Exacerbates Prostate Cancer Immune Evasion

    Investigators described that RelB participated in the immune evasion of prostate cancer via cis/trans transcriptional upregulation of programmed death receptor ligand (PD-L1).
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Dysregulation of the miRNome Unveils a Crosstalk between Obesity and Prostate Cancer: miR-107 as a Personalized Diagnostic and Therapeutic Tool

    Scientists assessed the dysregulation of the whole plasma miRNome in prostate cancer (PCa) patients, and its putative implication in PCa from a personalized perspective
    [Molecular Therapy-Nucleic Acids]

    AbstractFull ArticleGraphical Abstract

    Exercise in Advanced Prostate Cancer Elevates Myokine Levels and Suppresses In Vitro Cell Growth

    Researchers examined myokine levels of serum acquired from metastatic CRPC patients recruited to the INTERVAL-GAP4 trial before and after six months of exercise and its tumor-suppressive effect.
    [Prostate Cancer and Prostatic Diseases]

    Full Article

    KLK3 Germline Mutation I179T Complements DNA Repair Genes for Predicting Prostate Cancer Progression

    Germline mutations in DNA repair genes and KLK3 have been associated with adverse prostate cancer outcomes in separate studies but never jointly. The authors simultaneously assessed these two types of germline mutations.
    [Prostate Cancer and Prostatic Diseases]

    Abstract

    Silencing of LINC01963 Enhances the Chemosensitivity of Prostate Cancer Cells to Docetaxel by Targeting the miR-216b-5p/TrkB Axis

    Silencing LINC01963 inhibited TrkB protein level to enhance the chemosensitivity of PC3-DR to docetaxel by means of competitively binding to miR-216b-5p.
    [Laboratory Investigation]

    Full Article

    Identification of UAP1L1 as a Critical Factor for Prostate Cancer and Underlying Molecular Mechanism in Tumorigenicity

    The effects of UAP1-like-1 (UAP1L1) on prostate cancer were investigated by detecting the proliferation, migration, invasion and apoptosis of prostate cancer cells in vitro using MTT, wound healing, Transwell and flow cytometry assay, and the tumor growth in vivo.
    [Journal of Translational Medicine]

    Full Article

    Macrophages Connection: Aggressive Nanomechanical Phenotypes of Circulating Tumor Cells in Prostate Cancer

    Researchers showed that circulating tumor cells isolated from the blood of prostate cancer patients displayed specific nanomechanical phenotypes characteristic of cell endurance and invasiveness and patient sensitivity to androgen deprivation therapy.
    [Biophysical Journal]

    Abstract

    Cells in Motion: Model of Circulating Tumor Cells in Prostate Cancer

    Investigators noted that circulating tumor cells isolated from prostate cancer patients displayed a specific mechanical phenotype, determined with atomic force microscopy: high softness and high adhesion.
    [Biophysical Journal]

    Abstract

    Protease-Activated Receptor-2 Dependent and Independent Responses of Bone Cells to Prostate Cancer Cell Secretory Products

    Scientists investigated a possible role for protease-activated receptor-2 in regulating the behavior of bone cells exposed to metastatic prostate cancer cells.
    [Prostate]

    Abstract

    Request your free copy of the 'Directed Differentiation of Pluripotent Stem Cells' Wallchart
    REVIEWS

    Therapeutic Potential of p53 Reactivation in Prostate Cancer: Strategies and Opportunities

    The authors discuss the therapeutic potential of p53-reactivating compounds with a particular focus on the pharmacological rescue of p53 in metastatic prostate cancer.
    [European Journal of Pharmacology]

    AbstractGraphical Abstract

    INDUSTRY AND POLICY NEWS

    Lynparza plus Abiraterone Reduced Risk of Disease Progression by 34% vs. Standard-of-Care in First-Line Metastatic Castration-Resistant Prostate Cancer

    Positive results from the PROpel Phase III trial showed AstraZeneca and MSD’s Lynparza in combination with abiraterone demonstrated an improvement in radiographic progression-free survival versus current standard-of-care abiraterone as a first-line treatment for patients with metastatic CRPC.
    [AstraZeneca]

    Press Release

    NIH Issues a Seismic Mandate: Share Data Publicly

    In January 2023, the US National Institutes of Health (NIH) will begin requiring most of the 300,000 researchers and 2,500 institutions it funds annually to include a data management plan in their grant applications — and to eventually make their data publicly available.
    [Nature News]

    Press Release

    FEATURED EVENT

    The 37th Annual Congress of the European Association of Urology – Amsterdam

    March 18 – March 21
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Cell Viability

    Singapore-MIT Alliance for Research and Technology (SMART) Centre – Singapore, Singapore

    Postdoctoral Research Associate – Cancer Research

    University of Nebraska Medical Center – Omaha, Nebraska, United States

    Postdoctoral Positions – Translational 3D Pathology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Researcher – 3D Advanced Microscopy

    IRB Barcelona – Barcelona, Spain

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter